{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T09:58:33Z","timestamp":1774087113203,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.bbr.2026.116158","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:25:32Z","timestamp":1773188732000},"page":"116158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Empagliflozin and dapagliflozin, sodium glucose cotransporter 2 inhibitors, may improve cognitive dysfunctions: in silico and in vivo findings"],"prefix":"10.1016","volume":"506","author":[{"given":"Humeysa","family":"Kiyak-Kirmaci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayse Nur","family":"Hazar-Yavuz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elif Beyzanur","family":"Polat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammed Oguzhan","family":"Dogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatih","family":"Tok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozlem Tugce","family":"Cilingir-Kaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6386-1711","authenticated-orcid":false,"given":"Hatice Kubra","family":"Elcioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10284","key":"10.1016\/j.bbr.2026.116158_bib1","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.bbr.2026.116158_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.101979","article-title":"Antidiabetic agents as a novel treatment for Alzheimer\u2019s and Parkinson\u2019s disease","volume":"89","author":"Nowell","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"11","key":"10.1016\/j.bbr.2026.116158_bib3","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.2174\/1570159X18666200528142429","article-title":"Recent advancements in pathogenesis, diagnostics and treatment of Alzheimer\u2019s disease","volume":"18","author":"Khan","year":"2020","journal-title":"Curr. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.bbr.2026.116158_bib4","first-page":"251","article-title":"Lychee seed extract protects against neuronal injury and improves cognitive function in rats with type II diabetes mellitus with cognitive impairment","volume":"41","author":"Tang","year":"2018","journal-title":"Int. J. Mol. Med."},{"issue":"5","key":"10.1016\/j.bbr.2026.116158_bib5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.31083\/j.fbl2805103","article-title":"Sodium-glucose co-transporters family: current evidence, clinical applications and perspectives","volume":"28","author":"Nevola","year":"2023","journal-title":"Front. Biosci."},{"key":"10.1016\/j.bbr.2026.116158_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.106049","article-title":"Sodium glucose cotransporter 1 (SGLT1) inhibitors in cardiovascular protection: Mechanism progresses and challenges","volume":"176","author":"Li","year":"2022","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.bbr.2026.116158_bib7","doi-asserted-by":"crossref","first-page":"C240","DOI":"10.1152\/ajpcell.00317.2012","article-title":"Regional distribution of SGLT activity in rat brain in vivo","volume":"304","author":"Yu","year":"2013","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bbr.2026.116158_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.708547","article-title":"Role of DPP-4 and SGLT2 inhibitors connected to Alzheimer disease in type 2 diabetes mellitus","volume":"15","author":"Sim","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbr.2026.116158_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118974","article-title":"Intestinal sodium\/glucose cotransporter 3 expression is epithelial and downregulated in obesity","volume":"267","author":"Sot\u00e1k","year":"2021","journal-title":"Life Sci."},{"issue":"12","key":"10.1016\/j.bbr.2026.116158_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12122783","article-title":"The promising potency of sodium-glucose cotransporter 2 inhibitors in the prevention of and as treatment for cognitive impairment among type 2 diabetes patients","volume":"12","author":"Zhang","year":"2024","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.bbr.2026.116158_bib11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s40035-024-00431-y","article-title":"SGLT2 inhibitors: a novel therapy for cognitive impairment via multifaceted effects on the nervous system","volume":"13","author":"Mei","year":"2024","journal-title":"Transl. Neurodegener."},{"issue":"6","key":"10.1016\/j.bbr.2026.116158_bib12","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.3390\/neurolint16060124","article-title":"New insights into the role of SGLT-2 inhibitors in the prevention of dementia","volume":"16","author":"Hung","year":"2024","journal-title":"Neurol. Int."},{"issue":"13","key":"10.1016\/j.bbr.2026.116158_bib13","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera-a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"issue":"6","key":"10.1016\/j.bbr.2026.116158_bib14","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.str.2011.03.019","article-title":"A smoothed backbone-dependent rotamer library for proteins derived from adaptive kernel density estimates and regressions","volume":"19","author":"Shapovalov","year":"2011","journal-title":"Structure"},{"issue":"2","key":"10.1016\/j.bbr.2026.116158_bib15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jmgm.2005.12.005","article-title":"Automatic atom type and bond type perception in molecular mechanical calculations","volume":"25","author":"Wang","year":"2006","journal-title":"J. Mol. Graph. Model."},{"issue":"1","key":"10.1016\/j.bbr.2026.116158_bib16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: An open chemical toolbox","volume":"3","author":"O\u2019Boyle","year":"2011","journal-title":"J. Chemin."},{"issue":"16","key":"10.1016\/j.bbr.2026.116158_bib17","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"issue":"8","key":"10.1016\/j.bbr.2026.116158_bib18","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: New docking methods, expanded force field, and python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Cheml. Inf. Model."},{"issue":"2","key":"10.1016\/j.bbr.2026.116158_bib19","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"issue":"2-3","key":"10.1016\/j.bbr.2026.116158_bib20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0010-4655(96)00016-1","article-title":"Ewald summation techniques in perspective: a survey","volume":"95","author":"Toukmaji","year":"1996","journal-title":"Comput. Phys. Commun."},{"key":"10.1016\/j.bbr.2026.116158_bib21","unstructured":"Dassault Syst\u00e8mes BIOVIA. (2021). Discovery Studio Visualizer (Version 21.1.0). San Diego, CA: Dassault Syst\u00e8mes."},{"issue":"1","key":"10.1016\/j.bbr.2026.116158_bib22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12933-019-0964-4","article-title":"Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet\/streptozotocin-induced diabetic rats","volume":"18","author":"Shao","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"issue":"2","key":"10.1016\/j.bbr.2026.116158_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0263285","article-title":"SGLT2 inhibitor dapagliflozin prevents atherosclerotic and cardiac complications in experimental type 1 diabetes","volume":"17","author":"Hodrea","year":"2022","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.bbr.2026.116158_bib24","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1159\/000453216","article-title":"Resveratrol improves cognitive impairment by regulating apoptosis and synaptic plasticity in streptozotocin-induced diabetic rats","volume":"40","author":"Tian","year":"2016","journal-title":"Cell Physiol. Biochem."},{"issue":"2","key":"10.1016\/j.bbr.2026.116158_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/nu17020311","article-title":"The inhibitory effects of NCT503 and exogenous serine on high-selenium induced insulin resistance in mice","volume":"17","author":"Zhan","year":"2025","journal-title":"Nutrients"},{"key":"10.1016\/j.bbr.2026.116158_bib26","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3389\/fphar.2019.00395","article-title":"Apelin-13 suppresses neuroinflammation against cognitive deficit in a streptozotocin-induced rat model of Alzheimer\u2019s disease through activation of BDNF-TrkB signaling pathway","volume":"10","author":"Luo","year":"2019","journal-title":"Front. Pharm."},{"issue":"2","key":"10.1016\/j.bbr.2026.116158_bib27","doi-asserted-by":"crossref","first-page":"298","DOI":"10.29228\/jrp.128","article-title":"Sodium-glucose co-transporter inhibitor dapagliflozin attenuates cognitive deficits in sporadic Alzheimer\u2019s rat model","volume":"26","author":"Hazar-Yavuz","year":"2022","journal-title":"J. Res. Pharm."},{"issue":"2-3","key":"10.1016\/j.bbr.2026.116158_bib28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ejphar.2011.03.011","article-title":"Rivastigmine reverses aluminum-induced behavioral changes in rats","volume":"659","author":"Abdel-Aal","year":"2011","journal-title":"Eur. J. Pharm."},{"issue":"6","key":"10.1016\/j.bbr.2026.116158_bib29","doi-asserted-by":"crossref","first-page":"9131","DOI":"10.3892\/mmr.2017.7700","article-title":"Effects of butylphthalide on cognitive decline in diabetic rats","volume":"16","author":"Tian","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"8","key":"10.1016\/j.bbr.2026.116158_bib30","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1007\/s11064-018-2583-y","article-title":"Transient morphological alterations in the hippocampus after pentylenetetrazole-induced seizures in rats","volume":"43","author":"Vasilev","year":"2018","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbr.2026.116158_bib31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bbr.2017.03.044","article-title":"Protective effects of different exercise modalities in an Alzheimer\u2019s disease-like model","volume":"328","author":"\u00d6zbeyli","year":"2017","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.bbr.2026.116158_bib32","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0006-8993(97)00227-8","article-title":"Selegiline treatment after transient global ischemia in gerbils enhances the survival of CA1 pyramidal cells in the hippocampus","volume":"757","author":"Lahtinen","year":"1997","journal-title":"Brain Res."},{"issue":"11","key":"10.1016\/j.bbr.2026.116158_bib33","doi-asserted-by":"crossref","first-page":"F889","DOI":"10.1152\/ajprenal.00267.2015","article-title":"Renal sodium-glucose cotransporter inhibition in the management of type 2 diabetes mellitus","volume":"309","author":"Abdul-Ghani","year":"2015","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"11","key":"10.1016\/j.bbr.2026.116158_bib34","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1080\/14740338.2024.2396387","article-title":"Clinical features, treatment, and prognosis of SGLT2 inhibitors induced acute pancreatitis","volume":"24","author":"Li","year":"2025","journal-title":"Expert Opin. Drug Saf."},{"issue":"6","key":"10.1016\/j.bbr.2026.116158_bib35","doi-asserted-by":"crossref","first-page":"C1277","DOI":"10.1152\/ajpcell.00296.2010","article-title":"Functional expression of SGLTs in rat brain","volume":"299","author":"Yu","year":"2010","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"9","key":"10.1016\/j.bbr.2026.116158_bib36","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00424-020-02441-x","article-title":"Glucose transporters in brain in health and disease","volume":"472","author":"Koepsell","year":"2020","journal-title":"Pflug. Arch. Eur. J. Physiol."},{"issue":"5","key":"10.1016\/j.bbr.2026.116158_bib37","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/neup.12665","article-title":"Sodium\/glucose cotransporter 2 is expressed in choroid plexus epithelial cells and ependymal cells in human and mouse brains","volume":"40","author":"Chiba","year":"2020","journal-title":"Neuropathology"},{"issue":"9","key":"10.1016\/j.bbr.2026.116158_bib38","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00424-020-02441-x","article-title":"Glucose transporters in brain in health and disease","volume":"472","author":"Koepsell","year":"2020","journal-title":"Pflug. Arch."},{"issue":"2","key":"10.1016\/j.bbr.2026.116158_bib39","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1177\/13872877251329474","article-title":"Neuroprotective effects of SGLT2 inhibitors empagliflozin and dapagliflozin on A\u03b21-42-induced neurotoxicity and neuroinflammation in cellular models of Alzheimer\u2019s disease","volume":"105","author":"Alami","year":"2025","journal-title":"J. Alzheimer\u2019s Dis."},{"issue":"8","key":"10.1016\/j.bbr.2026.116158_bib40","doi-asserted-by":"crossref","DOI":"10.1111\/acel.70101","article-title":"SGLT2 inhibition by enavogliflozin significantly reduces A\u03b2 pathology and restores cognitive function via upregulation of microglial AMPK signaling in 5XFAD mouse model of Alzheimer's disease","volume":"24","author":"Han","year":"2025","journal-title":"Aging Cell"},{"issue":"1","key":"10.1016\/j.bbr.2026.116158_bib41","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s40035-024-00431-y","article-title":"SGLT2 inhibitors: a novel therapy for cognitive impairment via multifaceted effects on the nervous system","volume":"13","author":"Mei","year":"2024","journal-title":"Transl. Neurodegener."},{"issue":"23","key":"10.1016\/j.bbr.2026.116158_bib42","doi-asserted-by":"crossref","first-page":"7213","DOI":"10.3390\/molecules26237213","article-title":"Neuroprotective effect of SGLT2 inhibitors","volume":"26","author":"Pawlos","year":"2021","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.bbr.2026.116158_bib43","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209805","article-title":"SGLT2 inhibitor use and risk of dementia and Parkinson disease among patients with type 2 diabetes","volume":"103","author":"Kim","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2026.116158_bib44","first-page":"1479","article-title":"Cholinesterase inhibitors as Alzheimer's therapeutics","author":"Sharma","year":"2019","journal-title":"Mol. Med. Rep. 20(2"},{"key":"10.1016\/j.bbr.2026.116158_bib45","article-title":"Diabetes-linked metabolic dysfunction relates with distinct tau phosphorylation patterns, neuroinflammation and cognitive impairment in mouse models of Alzheimer's disease","volume":"132","author":"Vargas-Soria","year":"2025","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.bbr.2026.116158_bib46","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcad356","article-title":"Role of oxidative stress in neurodegenerative disorders: a review of reactive oxygen species and prevention by antioxidants","volume":"6","author":"Houldsworth","year":"2024","journal-title":"Brain Commun."},{"key":"10.1016\/j.bbr.2026.116158_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154887","article-title":"Quercetin: a promising therapy for diabetic encephalopathy through inhibition of hippocampal ferroptosis","volume":"126","author":"Cheng","year":"2024","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.bbr.2026.116158_bib48","doi-asserted-by":"crossref","DOI":"10.1111\/ejn.70364","article-title":"Type 3 diabetes: a molecular link between cerebral insulin resistance and neurodegeneration via AGE-RAGE signaling","volume":"63","author":"Verma","year":"2026","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbr.2026.116158_bib49","article-title":"The Role of NLRP3 Inflammasome in Alzheimer\u2019s disease and potential therapeutic targets","volume":"13","author":"Liang","year":"2022","journal-title":"Front. Pharm."},{"issue":"1","key":"10.1016\/j.bbr.2026.116158_bib50","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12974-023-02853-3","article-title":"Tau and neuroinflammation in Alzheimer's disease: interplay mechanisms and clinical translation","volume":"20","author":"Chen","year":"2023","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.bbr.2026.116158_bib51","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1007\/s00204-021-03115-y","article-title":"Differences in P-glycoprotein activity in human and rodent blood\u2013brain barrier assessed by mechanistic modelling","volume":"95","author":"Verscheijden","year":"2021","journal-title":"Arch. Toxicol."},{"issue":"7","key":"10.1016\/j.bbr.2026.116158_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2025.109063","article-title":"Effects of empagliflozin and dapagliflozin, SGLT2 inhibitors, on miRNA expressions in diabetes-related cardiovascular damage in rats","volume":"39","author":"Kiyak-Kirmaci","year":"2025","journal-title":"J. Diabetes Complicat."},{"issue":"2","key":"10.1016\/j.bbr.2026.116158_bib53","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1177\/13872877251329474","article-title":"Neuroprotective effects of SGLT2 inhibitors empagliflozin and dapagliflozin on A\u03b2(1-42)-induced neurotoxicity and neuroinflammation in cellular models of Alzheimer's disease","volume":"105","author":"Alami","year":"2025","journal-title":"J. Alzheimers Dis."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432826001348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432826001348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T09:09:23Z","timestamp":1774084163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432826001348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":53,"alternative-id":["S0166432826001348"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2026.116158","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Empagliflozin and dapagliflozin, sodium glucose cotransporter 2 inhibitors, may improve cognitive dysfunctions: in silico and in vivo findings","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2026.116158","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116158"}}